Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Heidelberg, Germany.
Unit of Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Gastroenterology. 2014 Mar;146(3):709-17. doi: 10.1053/j.gastro.2013.09.001. Epub 2013 Sep 5.
BACKGROUND & AIMS: Data from randomized controlled trials on the effects of screening colonoscopies on colorectal cancer (CRC) incidence and mortality are not available. Observational studies have suggested that colonoscopies strongly reduce the risk of CRC, but there is little specific evidence on the effects of screening colonoscopies.
We performed a population-based case-control study of 3148 patients with a first diagnosis of CRC (cases) and 3274 subjects without CRC (controls) from the Rhine-Neckar region of Germany from 2003 to 2010. Detailed information on previous colonoscopy and potential confounding factors was collected by standardized personal interviews. Self-reported information on colonoscopies and their indications was validated by medical records. We used multiple logistic regression to assess the association between colonoscopy conducted for specific indications within the past 10 years and risk of CRC.
A history of colonoscopy was associated with a reduced subsequent risk of CRC, independently of the indication for the examination. However, somewhat stronger associations were found for examinations with screening indications (adjusted odds ratio [OR] 0.09, 95% confidence interval [CI] 0.07-0.13) than for examinations with diagnostic indications, such as positive fecal occult blood test result (OR, 0.33; 95% CI, 0.19-0.57), surveillance after a preceding colonoscopy (OR, 0.33; 95% CI, 0.24-0.45), rectal bleeding (OR, 0.28; 95% CI, 0.20-0.40), abdominal symptoms (OR, 0.15; 95% CI, 0.10-0.21), or other (OR, 0.21; 95% CI, 0.14-0.30). Colonoscopy was also associated with a reduced risk of cancer in the right colon, regardless of the indication, although to a smaller extent than for other areas of the colon (OR for screening colonoscopy, 0.22; 95% CI, 0.14-0.33).
In a population-based case-control study, the risk of CRC was strongly reduced up to 10 years after colonoscopy for any indication. Risk was particularly low after screening colonoscopy, even for cancer in the right colon.
目前尚无随机对照试验关于结肠镜筛查对结直肠癌(CRC)发病率和死亡率影响的数据。观察性研究表明,结肠镜检查可显著降低 CRC 的风险,但关于筛查结肠镜检查效果的具体证据有限。
我们开展了一项基于人群的病例对照研究,纳入了 2003 年至 2010 年德国莱茵-内卡地区首次诊断为 CRC(病例)的 3148 例患者和无 CRC 的 3274 例对照。通过标准化的个人访谈收集了有关既往结肠镜检查和潜在混杂因素的详细信息。通过病历对结肠镜检查及其适应证的自述信息进行了验证。我们采用多因素 logistic 回归分析评估了过去 10 年内因特定适应证行结肠镜检查与 CRC 风险之间的关系。
无论检查适应证如何,有结肠镜检查史者 CRC 发病风险均显著降低。然而,与阳性粪便潜血试验结果(OR,0.33;95%CI,0.19-0.57)、结肠镜检查后随访(OR,0.33;95%CI,0.24-0.45)、直肠出血(OR,0.28;95%CI,0.20-0.40)、腹部症状(OR,0.15;95%CI,0.10-0.21)或其他(OR,0.21;95%CI,0.14-0.30)等诊断性适应证相比,筛查性适应证(调整 OR 0.09,95%CI 0.07-0.13)下的相关性更强。无论适应证如何,结肠镜检查均与右半结肠癌发病风险降低相关,尽管相关性低于其他结肠部位(筛查性结肠镜检查 OR,0.22;95%CI,0.14-0.33)。
在基于人群的病例对照研究中,任何适应证的结肠镜检查后 10 年内 CRC 发病风险均显著降低。对于右半结肠癌,筛查性结肠镜检查的风险尤其低。